BACK · As filed with the SEC
IMAC Holdings cash flow statement, by fiscal year
The statement as IMAC Holdings presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Consolidated Statements of Cash Flows · USD
| USD | FY2024 Year ended Dec 31, 2024 | FY2023 Year ended Dec 31, 2023 | FY2022 Year ended Dec 31, 2022 | FY2021 Year ended Dec 31, 2021 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Profit or Loss | — | — | — | (10,542,247) |
| Net Income | — | (9,418,585) | (18,312,806) | — |
| Net loss | (9,045,827) | — | — | — |
| Net loss from discontinuing operations | (2,748,049) | — | — | — |
| Profit or Loss | (6,297,778) | — | — | — |
| Adjustments to reconcile net loss to net cash from operating activities: | ||||
| Depreciation Expense | — | — | — | 1,649,187 |
| Stock-Based Compensation Expense | — | — | — | 570,513 |
| Loss on disposition of assets | — | — | — | 149,464 |
| Depreciation Expense | 139,182 | 403,593 | 1,626,614 | — |
| Interest Expense | 640,000 | — | — | — |
| Stock-Based Compensation Expense | 35,415 | 83,031 | 444,503 | — |
| Loss on disposition of assets | — | 1,475,289 | 98,116 | — |
| Asset Impairment Charges | — | 3,519,322 | 8,333,687 | — |
| Gain on lease modification | — | — | — | (57,086) |
| Interest Expense | — | — | — | 312,857 |
| Provision for Doubtful Accounts (CF) | — | 431,671 | — | — |
| Gain on extinguishment of debt | — | (94,346) | — | — |
| Changes in operating assets and liabilities: | ||||
| Accounts receivable, net | (28,030) | 1,449,569 | (1,671,906) | 304,350 |
| Other assets | — | — | 180,178 | (158,834) |
| Other assets | — | 265,553 | — | — |
| Prepaid expenses and other current assets | 33,360 | — | — | — |
| Net Cash from Operating Activities | — | 196,121 | — | — |
| Net Cash from Operating Activities | — | 205,389 | 56,620 | 36,357 |
| Decrease in right of use/lease liability | — | — | — | (162,797) |
| Right of use/lease liability | — | — | (149,631) | — |
| Liability to issue common stock | — | (329,855) | — | — |
| Right of use/lease liability | — | (346,770) | — | — |
| Accounts payable and accrued expenses | 5,063,810 | (388,467) | (820,592) | 281,428 |
| Patient deposits | — | — | (79,251) | 25,846 |
| Patient deposits | — | (241,666) | — | — |
| Net cash used in operating activities from continuing operations | (414,041) | — | — | — |
| Net Cash from Operating Activities | (2,748,049) | — | — | — |
| Net cash used in operating activities | (3,162,090) | (2,790,151) | (10,294,468) | (7,590,962) |
| Cash flows from investing activities: | ||||
| Purchase of property and equipment | — | — | (331,382) | (694,376) |
| Brand development | — | — | — | (69,070) |
| Acquisitions | — | — | — | (1,718,500) |
| Note receivable | (375,000) | (3,000,000) | — | — |
| Proceeds from sale of practices | — | 224,700 | — | — |
| Proceeds from Sale of PP&E | — | 1,000,000 | 71,400 | 24,450 |
| Net cash used in investing activities | (375,000) | (1,775,300) | (259,982) | (2,457,496) |
| Cash flows from financing activities: | ||||
| Stock Repurchases (Issuances) | — | 16,650 | 4,472,219 | 19,005,323 |
| Proceeds from Stock Issuance | 2,221,492 | 4,045,000 | — | — |
| Payments on notes payable | — | (10,350) | (254,488) | (4,436,375) |
| Proceeds from Notes Payable | 1,600,000 | — | — | — |
| Payments on finance lease obligation | (1,724) | (27,549) | (19,050) | (25,462) |
| Net cash from financing activities | 3,819,768 | 4,023,751 | 4,198,681 | 14,543,486 |
| Net increase (decrease) in cash | 282,678 | (541,700) | (6,355,769) | 4,495,028 |
| Cash, beginning of year | 221,511 | 763,211 | 7,118,980 | 2,623,952 |
| Cash, end of year | 504,189 | 221,511 | 763,211 | 7,118,980 |
| Supplemental cash flow information: | ||||
| Interest Expense | — | 129,981 | 14,191 | 239,011 |
| Business acquisition via stock issuance | — | — | — | 1,200,000 |
| Preferred stock conversion | 2 | — | — | — |
| Accrued dividends | 1,251,000 | 130,000 | — | — |
| Settlement of notes receivable in connection with asset purchase agreement | 1,044,000 | — | — | — |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.